Seeking Alpha

AspenBio Pharma (APPY -13.8%) falls after pricing its previously announced secondary offering of...

AspenBio Pharma (APPY -13.8%) falls after pricing its previously announced secondary offering of 1.5M shares at $2.10 each, a 15% discount to Wednesday's close. The diagnostic-product developer has a 7.7M share float outstanding at the beginning of November.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)